Description:
Home Page: www.fibrogen.com
409 Illinois Street
San Francisco,
CA
94158
United States
Phone:
415 978 1200
Officers
| Name | Title |
|---|---|
| Mr. Enrique A. Conterno | CEO & Director |
| Mr. Juan Graham | Chief Financial Officer |
| Dr. Elias Kouchakji | Sr. VP of Clinical Devel., Drug Safety & Pharmacovigilance |
| Ms. Christine L. Chung | Sr. VP of China Operations |
| Mr. Thane Wettig | Exec. VP & Chief Commercial Officer |
| Dr. Mark Eisner M.D., M.P.H. | Exec. VP & Chief Medical Officer |
| Dr. Barry A. Berkowitz Ph.D. | Founder |
| Dr. John J. Hunter Ph.D. | Chief Scientific Officer |
| Ms. Karen L. Bergman | VP of Investor Relations & Corp. Communications |
| Mr. Michael D. Lowenstein J.D., Ph.D. | Chief Legal Officer |
Exchange: MX
Country: MX
Currency: Mexican Peso (₱)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 80 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 54.4456 |
| Price-to-Sales TTM: | 8.8834 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 592 |